MUC1 and adenocarcinoma: After single and combined treatment, MUC-1 did not show any significant change in its level compared to SDT, while ductal/adenocarcinoma (CA19-9 and CK-19) and acinar (trypsin and chymotrypsin) markers were significantly (p < 0.05) reduced after hormonal treatment compared to SDT.